Gamelin, F. X., Aucouturier, J., Iannotti, F. A., Piscitelli, F., Mazzarella, E., Aveta, T., ... & Di Marzo, V. (2019). Effects of chronic cannabidiol treatment and resistance training on muscular strength and mass in rats. Frontiers in Physiology, 10, 704. https://www.frontiersin.org/articles/10.3389/fphys.2019.00704/full
García-Ovejero, D., Arevalo-Martin, A., Petrosino, S., Docagne, F., Hagen, C., Bisogno, T., ... & Guaza, C. (2013). The endocannabinoid system is modulated in response to exercise in MS patients. Multiple Sclerosis Journal, 19(4), 553-561. https://journals.sagepub.com/doi/full/10.1177/1352458512464584
Gobbi, G., Atkin, T., Zytynski, T., Wang, S., Askari, S., Boruff, J., ... & Mayo, N. (2019). Cannabinoids for the treatment of neuropsychiatric symptoms in dementia: a systematic review and meta-analysis. Drugs & Aging, 36(12), 1083-1096. https://link.springer.com/article/10.1007/s40266-019-00735-1
Huestis, M. A., & Mazzoni, I. (2015). Cannabis in sport: anti-doping perspective. Sports Medicine, 45(4), 543-554. https://link.springer.com/article/10.1007/s40279-015-0308-8
Willeit, P., Kaser, S., Chmelik, M., Groschner, K., Klingenschmid, G., Hauser, M., ... & Gerstenbrand, F. (2013). Cannabinoid receptor type 1 availability in the amygdala mediates threat processing in trauma survivors. Neuropharmacology, 72, 13-19. https://www.sciencedirect.com/science/article/abs/pii/S0028390813001576
Comments (0)